GLP-1
Surgery, GLP-1 Combo Can Optimize Outcomes, Expert Says
Weight-loss medications such as glucagon-like peptide-1 receptor agonists are occasionally maligned by surgeons, ...
JUNE 25, 2025
Critical Appraisal of the New GLP-1 Perioperative Guidance
We are writing to express our serious concerns regarding the recent publication of the “new multisociety ...
MAY 28, 2025
Greater Weight Loss With Roux-en-Y Conversion Than GLP-1s in Sleeve Gastrectomy Patients
Sleeve gastrectomy patients who undergo conversion to gastric bypass experience a greater level of sustained, ...
MAY 7, 2025
GLP-1 Agents May Drive Surgery Volume, Experts Predict
With the rising popularity of glucagon-like peptide-1 agents, many metabolic bariatric surgery programs across the ...
NOVEMBER 19, 2024
Endoscopy in Patients on GLP-1 Receptor Agonists: Expert Perspective
The use of GLP-1s has exploded over the past year, but this growth has raised concerns about potential adverse ...
SEPTEMBER 30, 2024
Surgery Bests Lifestyle Changes, GLP-1s for Durable Weight Loss
Bariatric surgery far outperforms lifestyle interventions and glucagon-like peptide-1 medications at maintaining ...
SEPTEMBER 19, 2024
Multimodal Meds Boost Pre-op Weight Loss In High-BMI Patients
A combo of multimodal medications and medically supervised weight loss is significantly more effective in ...
AUGUST 16, 2024
Anti-Obesity Medications: Their Current and Future Role in Bariatric Surgery
Overweight and obesity have steadily increased in prevalence over the past several decades worldwide.
JUNE 28, 2024
The Incretin Effect
I remember the discovery of glucagon-like peptide-1 (GLP-1) sometime in the late 1980s.
MARCH 5, 2024
New Study Links GLP-1 Agonists to Serious GI AEs
The popular drugs are associated with serious GI adverse effects such as pancreatitis, gastroparesis and bowel ...
JANUARY 16, 2024
